Identification of CD4+ Conventional T Cells-Related lncRNA Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Breast Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of CD4+ Conventional T Cells-Related lncRNA Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Breast Cancer
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-05-04
DOI
10.3389/fimmu.2022.880769
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LncRNA PCAT7 promotes the malignant progression of breast cancer by regulating ErbB/PI3K/Akt pathway
- (2021) Jiaoqun Zhou et al. Future Oncology
- Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer
- (2021) Ran Xiao et al. Computational and Mathematical Methods in Medicine
- PSGL-1 Immune Checkpoint Inhibition for CD4+ T Cell Cancer Immunotherapy
- (2021) Julia M. DeRogatis et al. Frontiers in Immunology
- Long non-coding RNAs in the doxorubicin resistance of cancer cells
- (2021) Saeed Ashrafizaveh et al. CANCER LETTERS
- A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
- (2021) Kaiming Zhang et al. Frontiers in Molecular Biosciences
- Immune-Related Genes to Construct a Novel Prognostic Model of Breast Cancer: A Chemosensitivity-Based Study
- (2021) Zhi-Min Deng et al. Frontiers in Immunology
- Identification and validation of immune-related lncRNA prognostic signature for breast cancer
- (2020) Yong Shen et al. GENOMICS
- lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer
- (2020) Yaqiong Zhang et al. Breast Cancer
- Large-scale public data reuse to model immunotherapy response and resistance
- (2020) Jingxin Fu et al. Genome Medicine
- The network of non-coding RNAs and their molecular targets in breast cancer
- (2020) Francesca Crudele et al. Molecular Cancer
- Breast cancer: Biology, biomarkers, and treatments
- (2020) Khadijeh Barzaman et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Identification of long-term survival-associated gene in breast cancer
- (2020) Shipeng Ning et al. Aging-US
- Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges
- (2020) Debora de Melo Gagliato et al. BIODRUGS
- Identification and validation of stemness-related lncRNA prognostic signature for breast cancer
- (2020) Xiaoying Li et al. Journal of Translational Medicine
- A novel autophagy‐related lncRNA prognostic risk model for breast cancer
- (2020) Xiaoying Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature
- (2020) Wei Ma et al. Journal of Translational Medicine
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
- (2019) Yiran Liang et al. SEMINARS IN CANCER BIOLOGY
- Breast cancer prevention in high-risk women
- (2019) Mangesh A. Thorat et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Targeted Therapies for Triple-Negative Breast Cancer
- (2019) Tomas G. Lyons CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction
- (2019) Yaqiong Zhang et al. DNA AND CELL BIOLOGY
- LncRNA PVT1 links Myc to glycolytic metabolism upon CD4+ T cell activation and Sjögren's syndrome-like autoimmune response
- (2019) Jiayao Fu et al. JOURNAL OF AUTOIMMUNITY
- Tumor mutation burden, immune checkpoint crosstalk and radiosensitivity in single-cell RNA sequencing data of breast cancer
- (2019) Bum-Sup Jang et al. RADIOTHERAPY AND ONCOLOGY
- Microenvironment-regulated lncRNA-HAL is able to promote stemness in breast cancer cells
- (2019) Alfredo García-Venzor et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
- (2018) Chia-Wei Li et al. CANCER CELL
- MicroRNAs in regulatory T cells
- (2018) Krung Phiwpan et al. CANCER LETTERS
- Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
- (2018) Elham Azizi et al. CELL
- Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
- (2018) Lina Liu et al. MOLECULAR THERAPY
- Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
- (2018) Peter Savas et al. NATURE MEDICINE
- LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer
- (2018) Wenyan Zhao et al. Cancer Medicine
- Novel EXO-T vaccine using polyclonal CD4+ T cells armed with HER2-specific exosomes for HER2-positive breast cancer
- (2018) Rong Li et al. OncoTargets and Therapy
- Long non-coding RNAs and cervical cancer
- (2018) Hamid Aalijahan et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- LncRNA Expression in CD4+ T Cells in Neurosyphilis Patients
- (2017) Li-Li Liu et al. Frontiers in Cellular and Infection Microbiology
- Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets
- (2016) Subash Chandra Gupta et al. INTERNATIONAL JOURNAL OF CANCER
- Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer
- (2016) Yiwen Fang et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Breast Cancer Biomarkers: Risk Assessment, Diagnosis, Prognosis, Prediction of Treatment Efficacy and Toxicity, and Recurrence
- (2014) Amy Braden et al. CURRENT PHARMACEUTICAL DESIGN
- CD4+ follicular helper T cell infiltration predicts breast cancer survival
- (2013) Chunyan Gu-Trantien et al. JOURNAL OF CLINICAL INVESTIGATION
- Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells
- (2009) A. Corthay et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now